Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study
[11C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integr...
Gespeichert in:
| Veröffentlicht in: | Stroke (1970) 2004-04, Vol.35 (4), p.942-947 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 947 |
|---|---|
| container_issue | 4 |
| container_start_page | 942 |
| container_title | Stroke (1970) |
| container_volume | 35 |
| creator | IHARA, M TOMIMOTO, H SHIBASAKI, H FUKUYAMA, H ISHIZU, K MUKAI, T YOSHIDA, H SAWAMOTO, N INOUE, M DOI, T HASHIKAWA, K KONISHI, J |
| description | [11C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integrity in various brain structures and dementia in patients with leukoaraiosis.
Twelve patients with extensive leukoaraiosis on magnetic resonance imaging were divided into groups of patients with or without dementia. Based on a 2-compartment, 2-parameter model that included metabolite-corrected arterial input and PET-measured cerebral radioactivity, the distribution volume of FMZ (FMZ-V(d)) was calculated in various regions of interest by nonlinear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V(d), and data analysis was performed by statistical parametric mapping.
The presence of dementia was associated with a reduced FMZ-V(d) in widespread areas of the cerebral cortex, including the bilateral frontopolar and frontal/insular areas, the left temporo-occipital border areas, and the left marginal cortical areas.
Differences in neuronal integrity in the cerebral cortex might determine whether patients with leukoaraiosis become symptomatic or not. |
| doi_str_mv | 10.1161/01.STR.0000122624.32167.e0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71771359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71771359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c325t-de6fed4ad0e306f6ba6e9fd21450817d5c0cc43a01ed6614e6147b93a20317d13</originalsourceid><addsrcrecordid>eNpNkF9r3SAYh2WsrGfdvsKQwXaX1FeNOeldafcPCoOtuxaPvlndkpj5JozTi3722fVAK6g_8PmpPIy9BVEDGDgVUH-__laLMkBKI3WtJJi2RvGMbaCRutJGbp-zjRCqq6TuumP2kuhX4aXaNi_YMTSl2m6bDbu7RJ_REfI4cZ_yEr0b-A6n2xSiu8U5TsgzepyXlOkeov1Y8ugKyeey4rQQ_xuXGz7g-ju57GKiSGf8nM8lLDlNHMdIFEsoxfQzu_lmz2lZw_4VO-rdQPj6sJ-wHx8_XF98rq6-fvpycX5VeSWbpQpoegzaBYFKmN7snMGuDxJ0I7bQhsYL77VyAjAYAxrLbHedclKocgzqhL1_uHfO6c-KtNjyI4_D4CZMK9kW2hZU0xXw7AH0ORFl7O2c4-jy3oKw9_atAFvs20f79r99i6KU3xxeWXcjhsfqQXcB3h0AR8Vzn93kIz3hDEjdavUPVWaR0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71771359</pqid></control><display><type>article</type><title>Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>IHARA, M ; TOMIMOTO, H ; SHIBASAKI, H ; FUKUYAMA, H ; ISHIZU, K ; MUKAI, T ; YOSHIDA, H ; SAWAMOTO, N ; INOUE, M ; DOI, T ; HASHIKAWA, K ; KONISHI, J</creator><creatorcontrib>IHARA, M ; TOMIMOTO, H ; SHIBASAKI, H ; FUKUYAMA, H ; ISHIZU, K ; MUKAI, T ; YOSHIDA, H ; SAWAMOTO, N ; INOUE, M ; DOI, T ; HASHIKAWA, K ; KONISHI, J</creatorcontrib><description>[11C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integrity in various brain structures and dementia in patients with leukoaraiosis.
Twelve patients with extensive leukoaraiosis on magnetic resonance imaging were divided into groups of patients with or without dementia. Based on a 2-compartment, 2-parameter model that included metabolite-corrected arterial input and PET-measured cerebral radioactivity, the distribution volume of FMZ (FMZ-V(d)) was calculated in various regions of interest by nonlinear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V(d), and data analysis was performed by statistical parametric mapping.
The presence of dementia was associated with a reduced FMZ-V(d) in widespread areas of the cerebral cortex, including the bilateral frontopolar and frontal/insular areas, the left temporo-occipital border areas, and the left marginal cortical areas.
Differences in neuronal integrity in the cerebral cortex might determine whether patients with leukoaraiosis become symptomatic or not.</description><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/01.STR.0000122624.32167.e0</identifier><identifier>PMID: 15001785</identifier><identifier>CODEN: SJCCA7</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Aged ; Biological and medical sciences ; Cerebral Cortex - diagnostic imaging ; Cerebral Cortex - metabolism ; Cerebral Cortex - pathology ; Cerebrovascular Circulation ; Dementia, Vascular - diagnosis ; Dementia, Vascular - diagnostic imaging ; Dementia, Vascular - metabolism ; Female ; Flumazenil - metabolism ; Humans ; Ligands ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Neurology ; Oxygen Consumption ; Radioactive Tracers ; Receptors, GABA-A - metabolism ; Tomography, Emission-Computed ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Stroke (1970), 2004-04, Vol.35 (4), p.942-947</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c325t-de6fed4ad0e306f6ba6e9fd21450817d5c0cc43a01ed6614e6147b93a20317d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,3688,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15612474$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15001785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IHARA, M</creatorcontrib><creatorcontrib>TOMIMOTO, H</creatorcontrib><creatorcontrib>SHIBASAKI, H</creatorcontrib><creatorcontrib>FUKUYAMA, H</creatorcontrib><creatorcontrib>ISHIZU, K</creatorcontrib><creatorcontrib>MUKAI, T</creatorcontrib><creatorcontrib>YOSHIDA, H</creatorcontrib><creatorcontrib>SAWAMOTO, N</creatorcontrib><creatorcontrib>INOUE, M</creatorcontrib><creatorcontrib>DOI, T</creatorcontrib><creatorcontrib>HASHIKAWA, K</creatorcontrib><creatorcontrib>KONISHI, J</creatorcontrib><title>Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><description>[11C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integrity in various brain structures and dementia in patients with leukoaraiosis.
Twelve patients with extensive leukoaraiosis on magnetic resonance imaging were divided into groups of patients with or without dementia. Based on a 2-compartment, 2-parameter model that included metabolite-corrected arterial input and PET-measured cerebral radioactivity, the distribution volume of FMZ (FMZ-V(d)) was calculated in various regions of interest by nonlinear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V(d), and data analysis was performed by statistical parametric mapping.
The presence of dementia was associated with a reduced FMZ-V(d) in widespread areas of the cerebral cortex, including the bilateral frontopolar and frontal/insular areas, the left temporo-occipital border areas, and the left marginal cortical areas.
Differences in neuronal integrity in the cerebral cortex might determine whether patients with leukoaraiosis become symptomatic or not.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - diagnostic imaging</subject><subject>Cerebral Cortex - metabolism</subject><subject>Cerebral Cortex - pathology</subject><subject>Cerebrovascular Circulation</subject><subject>Dementia, Vascular - diagnosis</subject><subject>Dementia, Vascular - diagnostic imaging</subject><subject>Dementia, Vascular - metabolism</subject><subject>Female</subject><subject>Flumazenil - metabolism</subject><subject>Humans</subject><subject>Ligands</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Oxygen Consumption</subject><subject>Radioactive Tracers</subject><subject>Receptors, GABA-A - metabolism</subject><subject>Tomography, Emission-Computed</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF9r3SAYh2WsrGfdvsKQwXaX1FeNOeldafcPCoOtuxaPvlndkpj5JozTi3722fVAK6g_8PmpPIy9BVEDGDgVUH-__laLMkBKI3WtJJi2RvGMbaCRutJGbp-zjRCqq6TuumP2kuhX4aXaNi_YMTSl2m6bDbu7RJ_REfI4cZ_yEr0b-A6n2xSiu8U5TsgzepyXlOkeov1Y8ugKyeey4rQQ_xuXGz7g-ju57GKiSGf8nM8lLDlNHMdIFEsoxfQzu_lmz2lZw_4VO-rdQPj6sJ-wHx8_XF98rq6-fvpycX5VeSWbpQpoegzaBYFKmN7snMGuDxJ0I7bQhsYL77VyAjAYAxrLbHedclKocgzqhL1_uHfO6c-KtNjyI4_D4CZMK9kW2hZU0xXw7AH0ORFl7O2c4-jy3oKw9_atAFvs20f79r99i6KU3xxeWXcjhsfqQXcB3h0AR8Vzn93kIz3hDEjdavUPVWaR0Q</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>IHARA, M</creator><creator>TOMIMOTO, H</creator><creator>SHIBASAKI, H</creator><creator>FUKUYAMA, H</creator><creator>ISHIZU, K</creator><creator>MUKAI, T</creator><creator>YOSHIDA, H</creator><creator>SAWAMOTO, N</creator><creator>INOUE, M</creator><creator>DOI, T</creator><creator>HASHIKAWA, K</creator><creator>KONISHI, J</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040401</creationdate><title>Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study</title><author>IHARA, M ; TOMIMOTO, H ; SHIBASAKI, H ; FUKUYAMA, H ; ISHIZU, K ; MUKAI, T ; YOSHIDA, H ; SAWAMOTO, N ; INOUE, M ; DOI, T ; HASHIKAWA, K ; KONISHI, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c325t-de6fed4ad0e306f6ba6e9fd21450817d5c0cc43a01ed6614e6147b93a20317d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - diagnostic imaging</topic><topic>Cerebral Cortex - metabolism</topic><topic>Cerebral Cortex - pathology</topic><topic>Cerebrovascular Circulation</topic><topic>Dementia, Vascular - diagnosis</topic><topic>Dementia, Vascular - diagnostic imaging</topic><topic>Dementia, Vascular - metabolism</topic><topic>Female</topic><topic>Flumazenil - metabolism</topic><topic>Humans</topic><topic>Ligands</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Oxygen Consumption</topic><topic>Radioactive Tracers</topic><topic>Receptors, GABA-A - metabolism</topic><topic>Tomography, Emission-Computed</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IHARA, M</creatorcontrib><creatorcontrib>TOMIMOTO, H</creatorcontrib><creatorcontrib>SHIBASAKI, H</creatorcontrib><creatorcontrib>FUKUYAMA, H</creatorcontrib><creatorcontrib>ISHIZU, K</creatorcontrib><creatorcontrib>MUKAI, T</creatorcontrib><creatorcontrib>YOSHIDA, H</creatorcontrib><creatorcontrib>SAWAMOTO, N</creatorcontrib><creatorcontrib>INOUE, M</creatorcontrib><creatorcontrib>DOI, T</creatorcontrib><creatorcontrib>HASHIKAWA, K</creatorcontrib><creatorcontrib>KONISHI, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IHARA, M</au><au>TOMIMOTO, H</au><au>SHIBASAKI, H</au><au>FUKUYAMA, H</au><au>ISHIZU, K</au><au>MUKAI, T</au><au>YOSHIDA, H</au><au>SAWAMOTO, N</au><au>INOUE, M</au><au>DOI, T</au><au>HASHIKAWA, K</au><au>KONISHI, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>35</volume><issue>4</issue><spage>942</spage><epage>947</epage><pages>942-947</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><coden>SJCCA7</coden><abstract>[11C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integrity in various brain structures and dementia in patients with leukoaraiosis.
Twelve patients with extensive leukoaraiosis on magnetic resonance imaging were divided into groups of patients with or without dementia. Based on a 2-compartment, 2-parameter model that included metabolite-corrected arterial input and PET-measured cerebral radioactivity, the distribution volume of FMZ (FMZ-V(d)) was calculated in various regions of interest by nonlinear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V(d), and data analysis was performed by statistical parametric mapping.
The presence of dementia was associated with a reduced FMZ-V(d) in widespread areas of the cerebral cortex, including the bilateral frontopolar and frontal/insular areas, the left temporo-occipital border areas, and the left marginal cortical areas.
Differences in neuronal integrity in the cerebral cortex might determine whether patients with leukoaraiosis become symptomatic or not.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>15001785</pmid><doi>10.1161/01.STR.0000122624.32167.e0</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0039-2499 |
| ispartof | Stroke (1970), 2004-04, Vol.35 (4), p.942-947 |
| issn | 0039-2499 1524-4628 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71771359 |
| source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Aged Biological and medical sciences Cerebral Cortex - diagnostic imaging Cerebral Cortex - metabolism Cerebral Cortex - pathology Cerebrovascular Circulation Dementia, Vascular - diagnosis Dementia, Vascular - diagnostic imaging Dementia, Vascular - metabolism Female Flumazenil - metabolism Humans Ligands Magnetic Resonance Imaging Male Medical sciences Neurology Oxygen Consumption Radioactive Tracers Receptors, GABA-A - metabolism Tomography, Emission-Computed Vascular diseases and vascular malformations of the nervous system |
| title | Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: A positron emission tomography study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T15%3A58%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20cortical%20benzodiazepine%20receptors%20in%20symptomatic%20patients%20with%20leukoaraiosis:%20A%20positron%20emission%20tomography%20study&rft.jtitle=Stroke%20(1970)&rft.au=IHARA,%20M&rft.date=2004-04-01&rft.volume=35&rft.issue=4&rft.spage=942&rft.epage=947&rft.pages=942-947&rft.issn=0039-2499&rft.eissn=1524-4628&rft.coden=SJCCA7&rft_id=info:doi/10.1161/01.STR.0000122624.32167.e0&rft_dat=%3Cproquest_cross%3E71771359%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71771359&rft_id=info:pmid/15001785&rfr_iscdi=true |